References
1. Wu J T, Leung K, and Leung G M, Nowcasting and forecasting the
potential domestic and international spread of the 2019-nCoV outbreak
originating in Wuhan, China: a modelling study. The Lancet, 2020.395 (10225): p. 689-697.
2. Liu Y, Gayle A A, Wildersmith A, and Rocklov J, The
reproductive number of COVID-19 is higher compared to SARS coronavirus.Journal of Travel Medicine, 2020. 27 (2).
3. Al-Tawfiq J A, Asymptomatic coronavirus infection: MERS-CoV and
SARS-CoV-2 (COVID-19). Travel Med Infect Dis, 2020.27 (101608): p. 1-2.
4. Novel C P E R E, The epidemiological characteristics of an
outbreak of 2019 novel coronavirus diseases (COVID-19) in China.Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi, 2020.41 (2): p. 145.
5. Protocol for the Management of Asymptomatic Persons Infected with
COVID-19
Virus.Joint Taskforce on COVID-19 Prevention and Control, China State Council
6. Junfen L, Mengna W, Haocheng W, Tao Z, Chen W, and Fudong L,Epidemiological characteristics of coronavirus disease 2019 in
Zhejiang Province. Prev Med, 2020. 32 (03): p. 217-221+225.
7. Biyao L, Xiaohua Q, Min J, and Zhen W, Epidemiological
characteristics of imported COVID-19 cases from aboard to Zhejiang
Province Preventive Medicine, 2020: p. 1-9.
8. Hu S, Xu Q, Luo K, Yang H, Sun Q, Liu Z, et al.,Epidemiological characteristics of patients with coronavirus
disease 2019 in Hunan province. Pract Prev Med, 2020. 27 (04):
p. 385-388.
9. Jincheng L, Qin X, Yan W, Jie X, Yao H, Wenjun L, et al.,Analysis in characteristics of asymptomatic infection patients
with coronavirus disease 2019 in Yangzhou City of Jiangsu Province.Journal of Clinical Medicine in Practice, 2020. 24 (05): p.
10-13.
10. Pan X, Chen D, Xia Y, Wu X, Li T, Ou X, et al., Asymptomatic
cases in a family cluster with SARS-CoV-2 infection. The Lancet
Infectious Diseases, 2020. 20 (4): p. 410-411.
11. Bai Y, Yao L, Wei T, Tian F, Jin D, Chen L, et al., Presumed
asymptomatic carrier transmission of COVID-19. Jama, 2020.323 (14): p. 1406-1407.
12. Li P, Fu J, Li K, Chen Y, Wang H, Liu L, et al., Transmission
of COVID-19 in the terminal stage of incubation period: a familial
cluster. International Journal of Infectious Diseases, 2020.
13. Tong Z, Tang A, Li K, Li P, Wang H, Yi J, et al., Potential
presymptomatic transmission of SARS-CoV-2, Zhejiang province, China,
2020. Emerging infectious diseases, 2020. 26 (5): p. 1052.
14. Liu X, Liu F, Fan Q, Zheng W, Zhang D H, Zhang Q L, et al.,Report of COVID-19 family clustering epidemic caused by
asymptomatic infection. Chin J Public Health, 2020. 36 (03): p.
282-284.
15. Qian G, Yang N, Ma A H Y, Wang L, Li G, Chen X, et al.,COVID-19 Transmission Within a Family Cluster by Presymptomatic
Carriers in China. Clinical Infectious Diseases, 2020.
16. Ma W, Su B, Wu J, Chen F, Bu T, Cheng X, et al., Report of
COVID-19 family clustering epidemic caused by asymptomatic infection.Chin J Public Health, 2020. 36 (03): p. 277-281.
17. Tian Y, Wu Z, Han X, Wang Y, and Liu H, Epidemiological
investigation on the first family aggregation epidemic of novel
coronavirus pneumonia in Yangzhou Shanghai Journal of Preventive
Medicine, 2020: p. 1-7.DOI:
https://doi.org/10.19428/j.cnki.sjpm.2019.20117.
18. Liu G and Ma ZL,Family clustering of novel coronavirus disease 2019
in Liaoning province: a brief report. Chin J Public Health,, 2020.36 (03): p. 293-294.
19. Li C, Wu B, Luo F, and Zhang N, Clinical Study and CT Findings
of a Familial Cluster of Pneumonia with Coronavirus Disease 2019
(COVID-19) J Sichuan Univ ( Med Sci Edi ), 2020. 51 (02): p.
155-158.
20. Ye F, Xu S, Rong Z, Xu R, Liu X, Deng P, et al., Delivery of
infection from asymptomatic carriers of COVID-19 in a familial cluster.International Journal of Infectious Diseases, 2020.
21. Yang YL, Li LH , LI CF, YC X, and J P,A survey on clustering of novel coronavirus disease in families in Fengjie
county of Chongqing municipality. Chin J Public Health, 2020.36 (03): p. 285-288.
22. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al., Clinical
characteristics of coronavirus disease 2019 in China. New England
journal of medicine, 2020. 382 (18): p. 1708-1720.
23. Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, et al.,Characteristics of pediatric SARS-CoV-2 infection and potential
evidence for persistent fecal viral shedding. Nature medicine, 2020.26 (4): p. 502-505.
24. Dong Y, Fan Q, Wang Y, Li Y, Xia J, Yao J, et al., Analysis in
nucleic acid test results of patients with coronavirus disease 2019 in
Yangzhou City of Jiangsu Province. Journal of Clinical Medicine in
Practice, 2020. 24 (05): p. 6-9.
25. Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X, et al., Clinical
characteristics of 24 asymptomatic infections with COVID-19 screened
among close contacts in Nanjing, China. Science China Life Sciences,
2020: p. 1-6.
26. Tan C, Xiao Y, Meng X, Huang X, Li C, and Wu A, Asymptomatic
SARS-CoV-2 infections: what we need to know? Infection Control &
Hospital Epidemiology, 2020: p. 1-7.
27. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al.,SARS-CoV-2 viral load in upper respiratory specimens of infected
patients. New England Journal of Medicine, 2020. 382 (12): p.
1177-1179.
28. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C,
et al., Transmission of 2019-nCoV infection from an asymptomatic
contact in Germany. New England Journal of Medicine, 2020.382 (10): p. 970-971.
29. Lei M Y, Huang Y, Gou Y, Ping K K, Liu S B, Yao G H, et al.,Characteristics of cluster epidemic of 2019 novel coronavirus
disease in Guizhou province. Chin J Public Health, 2020: p. 1-5.
30. Liu Y C, Liao C H, Chang C F, Chou C C, and Lin Y R, A locally
transmitted case of SARS-CoV-2 infection in Taiwan. New England Journal
of Medicine, 2020. 382 (11): p. 1070-1072.
31. Lai C-C, Shih T-P, Ko W-C, Tang H-J, and Hsueh P-R, Severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus
disease-2019 (COVID-19): the epidemic and the challenges. International
journal of antimicrobial agents, 2020: p. 105924.
32. Yu P, Zhu J, Zhang Z, and Han Y, A familial cluster of
infection associated with the 2019 novel coronavirus indicating possible
person-to-person transmission during the incubation period. The Journal
of infectious diseases, 2020. 221 (11): p. 1757-1761.
33. Xuzhou municipal health commission. Notification of the epidemic
(no. 38) http://www.xzcdc.com/index.php/news/15484.html.
34. Inui S, Fujikawa A, Jitsu M, Kunishima N, Watanabe S, Suzuki Y, et
al., Chest CT findings in cases from the cruise ship “Diamond
Princess” with coronavirus disease 2019 (COVID-19). Radiology:
Cardiothoracic Imaging, 2020. 2 (2): p. e200110.
35. Wang Y, Chen J, and Wang X, CT image features of asymptomatic
patients with novel coronavirus pneumonia. Medical Journal of Wuhan
University, 2020. 41 (03): p. 353-356.
36. Asadi S, Bouvier N, Wexler A S, and Ristenpart W D, The
coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory
particles? 2020, Taylor & Francis.
37. Booth T F, Kournikakis B, Bastien N, Ho J, Kobasa D, Stadnyk L, et
al., Detection of airborne severe acute respiratory syndrome
(SARS) coronavirus and environmental contamination in SARS outbreak
units. The Journal of infectious diseases, 2005. 191 (9): p.
1472-1477.
38. van Doremalen N, Bushmaker T, Morris D H, Holbrook M G, Gamble A,
Williamson B N, et al., Aerosol and surface stability of
SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of
Medicine, 2020. 382 (16): p. 1564-1567.
39. JP D, The size and the duration of air-carriage of respiratory
droplets and droplet-nuclei. Epidemiology & Infection, 1946.44 (6): p. 471-479.
40. PAPINENI R S and ROSENTHAL F S, The size distribution of
droplets in the exhaled breath of healthy human subjects. Journal of
Aerosol Medicine, 1997. 10 (2): p. 105-116.
41. Morawska L, Johnson G, Ristovski Z, Hargreaves M, Mengersen K,
Corbett S, et al., Size distribution and sites of origin of
droplets expelled from the human respiratory tract during expiratory
activities. Journal of Aerosol Science, 2009. 40 (3): p.
256-269.
42. Asadi S, Wexler A S, Cappa C D, Barreda S, Bouvier N M, and
Ristenpart W D, Aerosol emission and superemission during human
speech increase with voice loudness. Scientific reports, 2019.9 (1): p. 1-10.
43. Lu X, Zhang L, Du H, Zhang J, Li Y Y, Qu J, et al., SARS-CoV-2
infection in children. New England Journal of Medicine, 2020.382 (17): p. 1663-1665.
44. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al.,Epidemiological characteristics of 2143 pediatric patients with
2019 coronavirus disease in China. Pediatrics, 2020.
45. Wei M, Yuan J, Liu Y, Fu T, Yu X, and Zhang Z-J, Novel
coronavirus infection in hospitalized infants under 1 year of age in
China. Jama, 2020. 323 (13): p. 1313-1314.
46. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al., Clinical
characteristics and intrauterine vertical transmission potential of
COVID-19 infection in nine pregnant women: a retrospective review of
medical records. The Lancet, 2020. 395 (10226): p. 809-815.
47. Zeng L, Tao X, Yuan W, Wang J, Liu X, and Liu Z, First case of
neonate infected with novel coronavirus pneumonia in China. Zhonghua er
ke za zhi= Chinese journal of pediatrics, 2020. 58 : p. E009.
48. Cao Q, Chen Y, Chen C, and Chiu C, SARS-CoV-2 infection in
children: Transmission dynamics and clinical characteristics. Journal
of the Formosan Medical Association, 2020. 119 (3): p. 670.
49. JW V t W, R P, and R V F, The role of BCG/PPD‐activated
macrophages in resistance against systemic candidiasis in mice.Scandinavian journal of immunology, 1992. 36 (5): p. 713-720.
50. Netea M G, Schlitzer A, Placek K, Joosten L A, and Schultze J L,Innate and adaptive immune memory: an evolutionary continuum in
the host’s response to pathogens. Cell host & microbe, 2019.25 (1): p. 13-26.
51. Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung S, Hayashi K, et
al., Estimation of the asymptomatic ratio of novel coronavirus
infections (COVID-19). medRxiv, 2020.
52. Battegay M, Kuehl R, Tschudin-Sutter S, Hirsch H H, Widmer A F, and
Neher R A, 2019-novel Coronavirus (2019-nCoV): estimating the case
fatality rate–a word of caution. Swiss medical weekly, 2020.150 (0506).
53. Information from the official website of the National Health
Commissionhttp://www.nhc.gov.cn/xcs/xxgzbd/gzbd_index.shtml
54. Mizumoto K, Kagaya K, Zarebski A, and Chowell G, Estimating
the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases
on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.Eurosurveillance, 2020. 25 (10): p. 2000180.
55. Qiu J, Covert coronavirus infections could be seeding new
outbreaks. Nature, 2020.